BRISTOL MYERS SQUIBB CO (BMY)
Clinical trial NCT05516537 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2026-08-01 → 2026-01-30 3. primary completion date: 2025-12-01 → 2025-12-31 4. enrollment: 100 → 121 participants 5. enrollment type: ESTIMATED → ACTUAL
📈 **POSITIVE** • Low confidence analysis (52%) • Moderate positive clinical data • Good growth prospects **Sentiment:** Positive (55%) **Content type:** Clinical